![Rachel Bragg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rachel Bragg
Corporate Officer/Principal bei PANBELA THERAPEUTICS, INC.
Profil
Rachel Bragg is currently working as the Vice President-Clinical Development at Panbela Therapeutics, Inc. She previously worked as the Director at South Carolina Ovarian Cancer Foundation from 2015 to 2017.
She also worked at PPD, Inc. as the Head-Hematology Oncology.
Aktive Positionen von Rachel Bragg
Unternehmen | Position | Beginn |
---|---|---|
PANBELA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.06.2021 |
Ehemalige bekannte Positionen von Rachel Bragg
Unternehmen | Position | Ende |
---|---|---|
South Carolina Ovarian Cancer Foundation | Direktor/Vorstandsmitglied | 01.01.2017 |
PPD, INC. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PANBELA THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
PPD, Inc.
![]() PPD, Inc. Miscellaneous Commercial ServicesCommercial Services PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. It operates through the Clinical Development Services and Laboratory Services segments. The Clinical Development Services segment focuses in early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment comprises of bioanalytical, vaccine sciences, GMP, central lab and biomarker testing. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
South Carolina Ovarian Cancer Foundation |